3 completed, 1 recruiting, 1 unknown. 2 Phase 3, 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
| Phase 4 | 2 | Completed 1, Recruiting 1 |
Follow anagliptin: new trials by email Literature Review of anagliptin trials Research Report on anagliptin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Glycemic Variability of Combination Therapies in T2DM Empagliflozin/Metformin, Anagliptin, Metformin - Type 2 Diabetes Mellitus (T2DM) | Phase 4 | Recruiting | JW Pharmaceutical | 178 | 2025-10-29 | 2026-03-02 |
| Korean Observational Study to Evaluate the Efficacy and Safety of Anagliptin Switching From Other DPP4is in type2 DM Anagliptin - Type 2 Diabetes Mellitus | Unknown | JW Pharmaceutical | 2448 | 2017-07-06 | 2021-04-29 | |
| Randomized Evaluation of Anagliptin Versus Sitagliptin On Low-density lipoproteiN Cholesterol in Diabetes Trial Anagliptin, Sitagliptin - Dipeptidyl-Peptidase 4 Inhibitors, LDL Cholesterol | Phase 4 | Completed | Institute for Clinical Effectiveness, Japan | 353 | 2015-04-01 | 2019-08-28 |
| Efficacy and Safety of CWP-0403 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin Alone Anagliptin, Sitagliptin - Type 2 Diabetes Mellitus | Phase 3 | Completed | JW Pharmaceutical | 200 | 2011-05-01 | 2014-05-14 |
| A Study to Efficacy and Safety of CWP-0403 in Type 2 Diabetes Mellitus Patients Anagliptin, Placebo of Anagliptin - Type 2 Diabetes Mellitus | Phase 3 | Completed | JW Pharmaceutical | 117 | 2011-05-01 | 2013-01-04 |
Diabetes Mellitus, Type 2 (4) · Coronary Disease (1) · Diabetes Mellitus (1)
JW Pharmaceutical (4) · Institute for Clinical Effectiveness, Japan (1)
South Korea (4) · Japan (1)
Shinichiro Ueda, MD, PhD (1) · Sung Rae Kim (1) · Sung Woo Park, M.D., PhD (1)